Unknown

Dataset Information

0

New antibiotic dosing in infants.


ABSTRACT: To prevent the devastating consequences of infection, most infants admitted to the neonatal intensive care unit are exposed to antibiotics. However, dosing regimens are often extrapolated from data in adults and older children, increasing the risk for drug toxicity and lack of clinical efficacy because they fail to account for developmental changes in infant physiology. However, newer technologies are emerging with minimal-risk study designs, including ultra-low-volume assays, pharmacokinetic modeling and simulation, and opportunistic drug protocols. With minimal-risk study designs, pharmacokinetic data and dosing regimens for infants are now available for ampicillin, clindamycin, meropenem, metronidazole, and piperacillin/tazobactam.

SUBMITTER: Pineda LC 

PROVIDER: S-EPMC4703883 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

New antibiotic dosing in infants.

Pineda Leslie C LC   Watt Kevin M KM  

Clinics in perinatology 20141127 1


To prevent the devastating consequences of infection, most infants admitted to the neonatal intensive care unit are exposed to antibiotics. However, dosing regimens are often extrapolated from data in adults and older children, increasing the risk for drug toxicity and lack of clinical efficacy because they fail to account for developmental changes in infant physiology. However, newer technologies are emerging with minimal-risk study designs, including ultra-low-volume assays, pharmacokinetic mo  ...[more]

Similar Datasets

| S-EPMC7687048 | biostudies-literature
| S-EPMC10900833 | biostudies-literature
| S-EPMC11001217 | biostudies-literature
| S-EPMC7915319 | biostudies-literature
| S-EPMC10667364 | biostudies-literature
| S-EPMC8708464 | biostudies-literature
| S-EPMC9007841 | biostudies-literature
| S-EPMC10278304 | biostudies-literature
| S-EPMC5720916 | biostudies-literature
| S-EPMC7010644 | biostudies-literature